Shimizu A, Seki T, Ohyama K, Takahashi T, Takuma Y, Hirai K, Aihara M, Hatakeyama K
No To Hattatsu. 1989 Sep;21(5):445-52.
Serum cortisol, prolactin (PRL), TSH, GH, LH and FSH levels were measured before and immediately after daily ACTH-Z therapy (0.01 mg/kg/day, 1-2 weeks) for 5 patients with infantile spasms and one patient with myoclonus epilepsy. Total number of ACTH-Z therapy were 8 times, and all patients became seizure free after ACTH-Z therapy. In 6 occasions, TRH, LH-RH and insulin tolerance tests were performed before and after daily ACTH-Z therapy. Serum cortisol levels were significantly increased after daily ACTH-Z therapy but all other hormone levels were significantly decreased. In TRH and LH-RH tolerance tests, peak levels and increments of PRL, LH and FSH were significantly decreased after daily ACTH-Z therapy and those of TSH were mildly decreased. In one case insulin tolerance test revealed an adequate decrease of blood glucose before and after ACTH-Z therapy, and there was a poor GH response after ACTH-Z therapy. Daily ACTH-Z therapy was thought to suppress secretion of anterior pituitary hormones.
对5例婴儿痉挛症患者和1例肌阵挛性癫痫患者,在每日ACTH-Z治疗前及治疗后即刻(0.01mg/kg/天,1 - 2周)测定血清皮质醇、催乳素(PRL)、促甲状腺激素(TSH)、生长激素(GH)、促黄体生成素(LH)和促卵泡生成素(FSH)水平。ACTH-Z治疗总次数为8次,所有患者在ACTH-Z治疗后均无癫痫发作。在6次治疗中,于每日ACTH-Z治疗前后进行促甲状腺激素释放激素(TRH)、促黄体生成素释放激素(LH-RH)和胰岛素耐量试验。每日ACTH-Z治疗后血清皮质醇水平显著升高,但所有其他激素水平均显著降低。在TRH和LH-RH耐量试验中,每日ACTH-Z治疗后PRL、LH和FSH的峰值水平及增量显著降低,TSH的峰值水平及增量轻度降低。在1例患者的胰岛素耐量试验中,ACTH-Z治疗前后血糖有适当降低,且ACTH-Z治疗后生长激素反应不佳。每日ACTH-Z治疗被认为可抑制垂体前叶激素的分泌。